ASCO 2016

The American Society of Clinical Oncology (ASCO) will host its Annual Meeting on June 3-June 7, 2016, in Chicago, Illinois, at McCormick Place. This year’s meeting, Collective Wisdom: The Future of Patient-Centered Care and Research, is focused on integrating care and involving all stakeholder voice to improve outcomes in cancer patients. Sign up for our daily e-mail blasts on our registration page, and check back here during the conference for the full coverage.


   |    asco2016 > Surabhi Dangi-Garimella, PhD
A group in Israel presented a study that evaluated the price trend of 30 anticancer agents following their launch, and found that prices may increase by as much as 44% even after adjusting for inflation.
   |    asco2016 > Surabhi Dangi-Garimella, PhD
A poster presented at the annual meeting of the American Society of Clinical Oncology (ASCO) found that the cost per median month of survival for daratumumab was lower compared with 2 other novel treatments in multiple myeloma.
Dr Michael Kolodziej: Insurers May Never Use Value Frameworks
   |    asco2016
With value frameworks still in their infancy, Michael Kolodziej, MD, national medical director for oncology strategy at Aetna, doesn't see how his company can use them just yet. In fact, these frameworks may never be used by insurers, but only for shared decision making between the patient and provider.
   |    asco2016 > Surabhi Dangi-Garimella, PhD
A session at the ongoing annual meeting of the American Society of Clinical Oncology (ASCO) provided an overview of ASCO's recently updated value framework and their quality program, the Quality Oncology Practice Initiative.
   |    asco2016 > Surabhi Dangi-Garimella, PhD
While several clinical trials have tried to identify a programmed death-1 or programmed death ligand-1 expression–dependent response, it’s been an uphill task. During one of the sessions at the annual meeting of the American Society of Clinical Oncology, researchers were tasked with sharing their data on any breakthroughs or leads with biomarker-based treatment.
   |    asco2016 > Surabhi Dangi-Garimella, PhD
Drug costs are a significant contributor to rising healthcare costs, along with the cost of healthcare services. How can providers and patients work together to find a solution to this problem?
Patricia Goldsmith Describes the Financial Challenges Oncology Patients Face
   |    asco2016
CancerCare provides oncology patients with many services that offer both educational and financial support as well as any help the patient may need with his or her family, such as child care and housekeeping needs. However, Patricia Goldsmith, CEO of CancerCare, explained that there are many financial challenges, including transportation and high out-of-pocket costs, that oncology patients continue to face.
Dr John Fox: The Oncology Medical Home Model Can Decrease Costs
   |    asco2016
The key to driving down costs, or at the very least making costs more predictable, is integrating pathways into the Oncology Care Model program, said John L. Fox, MD, MS, associate vice president of medical affairs at Priority Health.
Adult ADHD Compendium
COPD Compendium
Dermatology Compendium
Diabetes Compendium
Hematology Compendium
Immuno-oncology Compendium
Lipids Compendium
MACRA Compendium
Neutropenia Compendium
Oncology Compendium
Pain Compendium
Reimbursement Compendium
Rheumatoid Arthritis Compendium
Know Your News
HF Compendium
Managed Care PODCAST
Upcoming Partner Events
October 24-25, 2017
San Francisco, CA